Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of the American College of Cardiology

• Publication date

  1989-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(89)90525-1PMID 2913120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.

  1988cited by this paper
• Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

  1988cited by this paper
• Amiodarone Pulmonary Toxicity: Recognition and Pathogenesis (Part 2)

  1988cited by this paper
• When "sudden cardiac death" is not so sudden: lessons learned from the automatic implantable defibrillator.

  1988cited by this paper
• Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy.

  1987cited by this paper
• Drug therapy: amiodarone

  1987cited by this paper
• Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease.

  1987cited by this paper
• The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias.

  1987cited by this paper
• Electrophysiologic testing and follow-up of patients with aborted sudden death.

  1987cited by this paper
• Long-term tolerance of amiodarone treatment for cardiac arrhythmias.

  1986cited by this paper
• Amiodarone: correlation of early and late electrophysiologic studies with outcome.

  1986cited by this paper
• Side effects and complications of amiodarone therapy.

  1985cited by this paper
• [Amiodarone pulmonary toxicity].

  1985cited by this paper
• Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.

  1985cited by this paper
• Gallium-67 lung uptake associated with amiodarone pulmonary toxicity.

  1985cited by this paper
• Amiodarone and the American Way.

  1985cited by this paper
• Serious adverse effects of amiodarones

  1984cited by this paper
• Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival.

  1984cited by this paper
• Prospective evaluation of amiodarone pulmonary toxicity.

  1984cited by this paper
• Determinants of survival in patients with ventricular tachyarrhythmias.

  1983cited by this paper
• Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.

  1983cited by this paper
• Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.

  1983cited by this paper
• Clinical Pharmacokinetics and Efficacy of Amiodarone for Refractory Tachyarrhythmias

  1983cited by this paper
• Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

  1983cited by this paper
• Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.

  1982cited by this paper
• Pneumonitis and Pulmonary Fibrosis Associated with Amiodarone Treatment: A Possible Complication of a New Antiarrhythmic Drug

  1982cited by this paper
• Amiodarone pulmonary toxicity.

  1982cited by this paper
• Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.

  1981cited by this paper
• Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

  1981cited by this paper
• AMIODARONE

  1979cited by this paper
• Clinical efficacy of amiodarone as an antiarrhythmic agent.

  1976cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper

• Plasma trimethylamine levels predict adverse cardiovascular events in sudden cardiac arrest Survivors: A prospective cohort study.

  2025cites this paper
• Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease

  2024cites this paper
• Siblings with Gorlin–Goltz syndrome associated with cardiac tumors: a case report and review of literature

  2023cites this paper
• Design, Synthesis, and Antiarrhythmic Activity of New Indole-3-carboxamide Derivatives

  2023cites this paper
• Design, synthesis and antiarrhythmic activity of new amide derivatives of indole-3-carboxylic acid

  2023cites this paper
• Catheter ablation of well tolerated ventricular tachycardia in patients with structural heart disease and without automatic defibrillator implantation: long term follow-up.

  2022cites this paper
• Clinical electrophysiology of the aging heart

  2022cites this paper
• Quinidine in the Management of Recurrent Ventricular Arrhythmias: A Reappraisal.

  2021cites this paper
• Indications for Implantable Cardioverter Defibrillators

  2020cites this paper
• Epidemiology of Pediatric Cardiac Arrest

  2020cites this paper
• Effects of amiodarone on rodent ventricular cardiomyocytes: Novel perspectives from a cellular model of Long QT Syndrome Type 3.

  2020cites this paper
• Programmed Electrical Stimulation-Guided Pharmacotherapy

  2020cites this paper
• Two Year Mortality of New York Heart Association (NYHA) Functional Class II and III Congestive Heart Failurep

  2017cites this paper
• Anti-arrhythmic medications increase non-cardiac mortality – A meta-analysis of randomized control trials

  2016cites this paper
• Arrhythmias in Cardiac Critical Care

  2016cites this paper
• Effects of Amledarone on Refractory Ventricular Fibrillation in Acute Myocardial Infametion : Experimental Study

  2016cites this paper
• The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure

  2016cites this paper
• Drug Treatment of Stable Coronary Artery Disease

  2016cites this paper
• Sudden Cardiac Death in Coronary Artery Disease

  2015cites this paper
• Clinical management and prevention of sudden cardiac death.

  2015cites this paper
• Comparison of Amiodarone Compliance Monitoring: Usual Care, Electronic Prescribing Template and Pharmacist-Managed Clinic

  2014cites this paper
• Treatment of ventricular arrhythmias

  2014cites this paper
• What internists should know about amiodarone

  2013cites this paper
• The Efficacy of Amiodarone‐Propranolol Combination for the Management of Childhood Arrhythmias

  2013cites this paper
• Rapid stimulating effect of the antiarrhythmic agent amiodarone on absorption of organic anion compounds.

  2013cites this paper
• Sudden Cardiac Death After Myocardial Infarction

  2012cites this paper
• The Value of Oral Amiodarone in the Treatment of Ventricular Arrhythmias in Heart Disease

  2012cites this paper
• Atrial Fibrillation Management in Elderly

  2012cites this paper
• Amiodarone in Long Term Prophylaxis

  2012cites this paper
• Pharmacology of antiarrhythmic drugs in elderly patients.

  2012cites this paper
• [Amiodaron: decades of administration].

  2011cites this paper
• Ventricular Tachycardia and Fibrillation: Pharmacologic Therapy

  2011cites this paper
• CHAPTER 19 – Electrophysiology, Pacing, and Devices

  2010cites this paper
• Implantable Cardioverter-Defibrillators

  2010cites this paper
• Management of ventricular arrhythmias.

  2010cites this paper
• CHAPTER 41 – Diagnosis and Management of Coronary Artery Disease

  2010cites this paper
• CHAPTER 45 – Cardiac Arrhythmias

  2010cites this paper
• Use of implantable cardioverter-defibrillators.

  2010cites this paper
• Strategies for the prevention and treatment of sudden cardiac death

  2010cites this paper
• Combined amiodarone and low‐dose carvedilol treatment for severe heart failure in childhood

  2010cites this paper
• Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia.

  2009cites this paper
• Treatment of Ventricular Arrhythmias in the Elderly

  2009cites this paper
• Acute and chronic management of atrial fibrillation in patients with late-stage CKD.

  2009cites this paper
• Electrical storms and their prognostic implications.

  2009cites this paper
• Toxicity in Doberman Pinchers with ventricular arrhythmias treated with amiodarone (1996-2005).

  2009cites this paper
• Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells.

  2009cites this paper
• Management of atrial fibrillation in the elderly.

  2009cites this paper
• Atrial Fibrillation: The New Epidemic of the Ageing World.

  2009cites this paper
• Off-pump coronary artery revascularization in octogenarians: is it better?

  2009cites this paper
• Amiodarone increases the accumulation of DEA in a human alveolar epithelium-derived cell line.

  2008cites this paper
• A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators.

  2008cites this paper
• Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with carvedilol therapy alone

  2008cites this paper
• Management of the older patient after myocardial infarction

  2008cites this paper
• Supraventricular tachyarrhythmias in the elderly

  2008cites this paper
• Ventricular arrhythmias in the elderly

  2008cites this paper
• Treatment of Atrial Fibrillation and Atrial Flutter: Part II

  2008cites this paper
• Treatment After Myocardial Infarction

  2007cites this paper
• Efflux transport of N-monodesethylamiodarone by the human intestinal cell-line Caco-2 cells.

  2007cites this paper
• Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter defibrillators.

  2007cites this paper
• Do patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter-defibrillators? Patients With Hemodynamically Tolerated Ventricular Tachycardia Require Implantable Cardioverter-Defibrillators

  2007cites this paper
• Cardiovascular Drug Therapy in the Elderly

  2007cites this paper
• All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator

  2007cites this paper
• Long‐term efficacy and safety of very‐low‐dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct‐current cardioversion

  2006cites this paper
• SD3212, a new antiarrhythmic drug, raises atrial fibrillation threshold in isolated rabbit hearts

  2006cites this paper
• “Torsade de Pointes” in Patients with Structural Heart Disease and Atrial Fibrillation Treated with Amiodarone, β‐Blockers, and Digitalis

  2006cites this paper
• Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine‐needle aspiration: Cytologic, histologic, and electronmicroscopic findings

  2006cites this paper
• Antiarrhythmic drug therapy

  2006cites this paper
• Sudden Cardiac Death

  2006cites this paper
• Original article

  2006cites this paper
• Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.

  2006cites this paper
• Ventricular Arrhythmias in the Elderly

  2006cites this paper
• Unexpected Cardiac Arrests in Hospitalized Heart Failure Patients Total Ventricular tachycardia / ventricular fibrillation Primary Ischemia / infarction Hyperkalemia Hypokalemia Torsade de pointes Bradyarrhythmic Primary Ischemialinfarction Hyperkalemia Hypoglycemia Electromechanical dissociation Pu

  2005cites this paper
• Synthesis and evaluation of the permeability transition inhibitory characteristics of paramagnetic and diamagnetic amiodarone derivatives.

  2005cites this paper
• Progression of amiodarone induced cataracts

  2005cites this paper
• Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles

  2005cites this paper
• Cardiac Arrest Survivors

  2005cites this paper
• Prevention of Sudden Cardiac Death

  2005cites this paper
• Management of the elderly person after myocardial infarction.

  2004cites this paper
• Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with β-blocker therapy

  2004cites this paper
• Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS)

  2004cites this paper
• Long‐Term Outcome of Patients Who Received Implantable Cardioverter Defibrillators for Stable Ventricular Tachycardia

  2004cites this paper
• Amiodarone: Maximising Survival Benefit with Empiric or Guided Therapy

  2004cites this paper
• Cardiovascular Drug Therapy in the Elderly: Theoretical and Practical Considerations

  2003cites this paper
• Amiodarone-associated “torsade de pointes”

  2003cites this paper
• Drug-Induced Lung Disease: A Pragmatic Classification Incorporating HRCT Appearances

  2003cites this paper
• Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.

  2003cites this paper
• Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.

  2002cites this paper
• Amiodarone induces apoptosis in L-132 human lung epithelial cell line.

  2002cites this paper
• Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.

  2002cites this paper
• Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease.

  2002cites this paper
• Management of the older person with atrial fibrillation.

  2002cites this paper
• Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.

  2002cites this paper
• Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.

  2002cites this paper
• Therapeutic use of amiodarone and attention to its side effects

  2002cites this paper
• Sympathetic Activation Enhances QT Prolongation by Quinidine

  2001cites this paper
• The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease.

  2001cites this paper
• Supraventricular tachycardia.

  2001cites this paper
• Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas

  2001cites this paper
• [Practice guidelines of the Spanish Society of Cardiology on cardiac arrythmias].

  2001cites this paper
• Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.

  2001cites this paper